The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 08, 2019

Filed:

Feb. 05, 2019
Applicant:

Hanmi Pharm. Co., Ltd., Gyeonggi-do, KR;

Inventors:

Sang Youn Hwang, Gyeonggi-do, KR;

Jin Young Kim, Gangwon-do, KR;

Seung Su Kim, Seoul, KR;

In Young Choi, Gyeonggi-do, KR;

Sung Youb Jung, Gyeonggi-do, KR;

Se Chang Kwon, Seoul, KR;

Assignee:

Hanmi Pharm. Co., Ltd., Hwaseong-Si, Gyeonggi-Do, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 16/00 (2006.01); A61K 38/26 (2006.01); A61K 47/60 (2017.01); A61K 47/68 (2017.01); A61K 49/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/00 (2013.01); A61K 38/26 (2013.01); A61K 47/60 (2017.08); A61K 47/6811 (2017.08); A61K 49/0008 (2013.01); C07K 2317/41 (2013.01); C07K 2317/53 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease including a long-acting GLP-1/glucagon receptor dual agonist, and a method for preventing or treatment of non-alcoholic fatty liver disease including administering the composition. The composition of the present invention either has no side effect of weight gain or reduces the side effect of weight gain, which is a side-effect of conventional therapeutic agents for non-alcoholic fatty liver disease, and reduces the amount of administrations of a long-acting GLP-1/glucagon receptor dual agonist, thus greatly improving patient's convenience. In addition, the long-acting GLP-1/glucagon receptor dual agonist of the present invention improves in vivo sustainability and stability.


Find Patent Forward Citations

Loading…